WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012107564) NOVEL FORMULATIONS FOR DERMAL, TRANSDERMAL AND MUCOSAL USE 1
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/107564    International Application No.:    PCT/EP2012/052325
Publication Date: 16.08.2012 International Filing Date: 10.02.2012
IPC:
A61K 9/00 (2006.01), A61K 47/06 (2006.01), A61K 47/10 (2006.01), A61K 47/14 (2006.01), A61K 9/70 (2006.01)
Applicants: MOBERG PHARMA AB [SE/SE]; Gustavslundsvägen 42, 5 tr S-167 51 Bromma (SE) (For All Designated States Except US).
LINDAHL, Åke [SE/SE]; (SE) (For US Only).
KAUFMANN, Peter [US/SE]; (SE) (For US Only)
Inventors: LINDAHL, Åke; (SE).
KAUFMANN, Peter; (SE)
Agent: MCNEENEY, Stephen P.; Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG (GB)
Priority Data:
61/441,346 10.02.2011 US
Title (EN) NOVEL FORMULATIONS FOR DERMAL, TRANSDERMAL AND MUCOSAL USE 1
(FR) NOUVELLES PRÉPARATIONS POUR UTILISATION CUTANÉE, TRANSCUTANÉE ET PAR VOIE MUQUEUSE
Abstract: front page image
(EN)A dermal, transdermal and/or mucosal formulation for topical application on skin, comprising an active pharmaceutical ingredient and a pharmaceutically acceptable solvent, and an anti-solvent; wherein the active pharmaceutical ingredient is soluble in the solvent in the absence of the anti-solvent, and wherein the active pharmaceutical ingredient is substantially in the solid state in the presence of the anti-solvent. A method for increasing the stability of an active pharmaceutical ingredient.
(FR)L'invention concerne une préparation pour utilisation cutanée, transcutanée et par voie muqueuse destinée à une application topique sur la peau, laquelle préparation comprend un ingrédient pharmaceutique actif et un solvant pharmaceutiquement acceptable ainsi qu'un anti-solvant. L'ingrédient pharmaceutique actif est soluble dans le solvant en l'absence de l'anti-solvant, l'ingrédient pharmaceutique actif est essentiellement à l'état solide en présence de l'anti-solvant. L'invention concerne un procédé permettant d'augmenter la stabilité d'un ingrédient pharmaceutique actif.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)